MICRO STENT(TM) QUANTITATIVE CORONARY ANGIOGRAPHY, AND PROCEDURAL RESULTS

The Micro stent(TM) (MS) is a radiopaque stainless steel balloon expan dable intracoronary stent. The stent is mounted on a rapid-exchange de livery system, From August 1994-March 1995, 127 MS were implanted in 8 5 patients (pts, 1.5 stents/pt, 85 in native vessels and 42 in bypass vein grafts, 61 male and 24 female, age 33-77 yr, mean age 61 +/- 10 y r), Pts studied were scheduled for either elective PTCA (n = 62, 73%) or PTCA for acute myocardial infarction (n = 23, 27%), Elective stent implantation was performed in 45 pts (53%). An MS was implanted becaus e of a suboptimal balloon angioplasty result in 26 pts (31%), The sten t was implanted because of threatened or acute vessel closure after ba lloon angioplasty in 14 pts (16%), During the procedure, 500 mg aspiri n and 2 x 7,500 units of heparin were administered intravenously, foll owed by systemic heparinization for 48 hr. Pts were discharged with 10 0 mg aspirin daily(n = 50, 59%), or anticoagulant drugs and 100 mg asp irin daily(n = 19, 22%), or anticoagulant drugs only(n = 16, 19%), Ang iographic results were analyzed with computer-assisted quantitative co ronary arteriography. Angiographic success (defined as a residual sten osis of <30%) was achieved in 124 of 127 attempts (98%). The mean mini mal luminal diameter of the target lesions increased from 0.88 +/- 0.7 9 mm before stent implantation to 3.08 +/- 0.56 mm (P < 0.001), The pe rcentage of diameter stenosis was reduced from 77.9 +/- 20.9% before t o 13.3 +/- 10.5% (P < 0.001) after stent implantation, The average ini tial gain was 2.53 +/- 1.37 mm. The procedural success rate (defined a s a residual stenosis of <30% without occurrence of major clinical eve nts within 3 wk after procedure) was 84%. Major clinical events includ ed: death 1 pt (1%); cerebrovascular accident, 1 pt (1%); subacute ste nt closure, 5 pts (6%); coronary artery bypass grafting, 3 pts (4%); f alse femoral aneurysm, 2 pts (2%), The initial results of Micro stent implantations are promising, No anticoagulant therapy was given to mos t of the patients (59%), Few vascular and bleeding complications were observed. However, at this stage, no data about the restenosis rate af ter implantation of a Micro stent are available. (C) 1996 Wiley-Liss, Inc.